PHILADELPHIA – Researchers from the Abramson Cancer Center (ACC) of the University of Pennsylvania and Penn’s Perelman School of Medicine will present data on the latest advances in blood cancer and classical hematology research at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition , taking place Dec. 6-9, 2025, in Orlando, Florida. For updates, follow Penn Medicine on LinkedIn , Threads , and X , and Penn MD Forum on X .
Hematology experts from Penn Medicine are available to comment on a wide range of research and care topics during the meeting onsite and by video call, phone, or email. To arrange interviews, please contact Meagan Raeke at Meagan.Raeke@pennmedicine.upenn.edu or 267-693-6224 .
Alison Wakoff Loren, MD, MSCE , division chief of Hematology-Oncology, has been elected to serve as the incoming vice president of the society . Loren will serve a one-year term as vice president starting after the 2025 Annual Meeting, followed by successive terms as president-elect and then will lead the organization as president. Additionally, Adam Cuker, MD, MS , was elected to a four-year term as councillor on the ASH Executive Committee.
Nancy A. Speck, PhD , the John W. Eckman Professor in Medical Science II and chair of the department of Cell and Developmental Biology, will be recognized at the Annual Meeting as the 2025 recipient of the E. Donnall Thomas Lecture and Prize for her pivotal work in hematopoiesis (the process of blood cell production) and leukemogenesis (the process of leukemia development).
Penn hematologist elected to lead American Society of Hematology
Nancy A. Speck honored for pioneering research in hematology
Check this page for additional releases as embargoes lift during the meeting .
Penn Medicine experts will present updates across the spectrum of preclinical, clinical, and population-based research in both classical and malignant hematology. Additionally, Penn experts are co-authors and major contributors to studies being presented in the Plenary Scientific Session and Late-Breaking Abstracts (LBA) Session. In the Plenary, a multicenter Phase II study, co-authored by Alexander Perl, MD , compared the standard intensive induction chemotherapy to a lower-intensity approach for newly diagnosed acute myeloid leukemia ( Plenary Presentation 6 ). In the LBA Session, results from a multicenter, randomized, double-blinded phase III study, co-authored by Adam Cuker, MD, MS , that investigated a monoclonal antibody as second-line treatment for immune thrombocytopenia, an autoimmune disorder that causes low platelet counts, leading to potentially life-threatening bleeding events ( LBA-2 ), will be presented.
Additional oral abstract highlights:
All locations are in the Orange County Convention Center in Orlando.
###
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine , founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $580 million awarded in the 2023 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Doylestown Health, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.9 billion enterprise powered by nearly 49,000 talented faculty and staff.